Trileptal is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Remedyrepack Inc.. The primary component is Oxcarbazepine.
Product ID | 70518-1349_72f2ec5a-e0fa-96ce-e053-2991aa0a7516 |
NDC | 70518-1349 |
Product Type | Human Prescription Drug |
Proprietary Name | Trileptal |
Generic Name | Oxcarbazepine |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 2018-08-07 |
Marketing Category | NDA / NDA |
Application Number | NDA021014 |
Labeler Name | REMEDYREPACK INC. |
Substance Name | OXCARBAZEPINE |
Active Ingredient Strength | 300 mg/1 |
Pharm Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2018-08-07 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA021014 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2018-08-07 |
Marketing End Date | 2020-05-20 |
Ingredient | Strength |
---|---|
OXCARBAZEPINE | 300 mg/1 |
SPL SET ID: | 52b9ff8a-34ea-435b-9c90-93d0df4eefa8 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0078-0337 | Trileptal | oxcarbazepine |
0078-0357 | Trileptal | oxcarbazepine |
0078-0456 | Trileptal | oxcarbazepine |
0078-0457 | Trileptal | oxcarbazepine |
70518-1300 | Trileptal | Trileptal |
70518-1349 | Trileptal | Trileptal |
55289-007 | Trileptal | Trileptal |
61919-569 | TRILEPTAL | TRILEPTAL |
0054-0097 | Oxcarbazepine | Oxcarbazepine |
0054-0098 | Oxcarbazepine | Oxcarbazepine |
0054-0099 | Oxcarbazepine | Oxcarbazepine |
0054-0199 | Oxcarbazepine | Oxcarbazepine |
0615-6593 | Oxcarbazepine | Oxcarbazepine |
0615-6594 | Oxcarbazepine | Oxcarbazepine |
0615-6595 | Oxcarbazepine | Oxcarbazepine |
0615-8153 | Oxcarbazepine | Oxcarbazepine |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
![]() TRILEPTAL 74519619 2186101 Live/Registered |
Novartis Corporation 1994-05-02 |